Zhuoyin Xue
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Depression of CaV1.2 activation and expression in mast cells ameliorates allergic inflammation diseases.
Journal: Journal of pharmaceutical analysis
Published: August 15, 2024
Inhibition of pseudo-allergic reactions by vitamin K3 directly targeting GAB1 in mast cells.
Journal: International immunopharmacology
Published: March 25, 2024
Secreted phosphoprotein 1 regulates natural compound 3',4',5,7-tetrahydroxyflavone to inhibit mast cell-mediated allergic inflammation.
Journal: Immunopharmacology and immunotoxicology
Published: June 20, 2023
Harringtonine: A more effective antagonist for Omicron variant.
Journal: Biochemical pharmacology
Published: February 22, 2023
α-Asarone alleviates allergic asthma by stabilizing mast cells through inhibition of ERK/JAK2-STAT3 pathway.
Journal: BioFactors (Oxford, England)
Published: May 14, 2022
Chrysin Inhibits Pseudo-allergic Reaction by Suppressing Mitochondrial STAT3 Activation via MAS-Related GPR Family Member X2.
Journal: Journal of agricultural and food chemistry
Published: June 08, 2021
Licochalcone A inhibits MAS-related GPR family member X2-induced pseudo-allergic reaction by suppressing nuclear migration of nuclear factor-κB.
Journal: Phytotherapy research : PTR
Published: April 25, 2021
Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein.
Journal: Journal of biochemical and molecular toxicology
Published: January 03, 2021
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.
Journal: Virology
Published: October 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026